International Conference and Exhibition on Cancer & Therapeutics

The goal of International Conference and Exhibition on Cancer & Therapeutics (ICECT USA 2018) is to improve the care of Cancer patients by updating the oncology care providers about the new developments in the field. This ICECT USA 2018 conference also provides attendees with opportunities to interact and network with top experts in Cancer Research.

ICECT USA 2018 conference, we will learn about the most recent advances in the field of Cancer therapeutics from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to cancer.

The main aims of this meeting are:

• To establish and develop the field of Cancer therapeutics in world.
• To bring together oncologists, hemato-oncologists and general practitioners from USA and worldwide.
• To bring together national and international medical and Para-medical disciplines involved, including the fields of imaging, biomarkers and others.
• To give stage for basic scientists and Pharma companies involved in the development of novel treatments with potential effects.

To contribute to the development of international recommendations and guidelines in the field.


The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in cancer and it types. The meeting agenda is developed by multidisciplinary faculty led by prominent world experts, including oncology team, hemato-oncology team. The meeting is held on Jan 29-31, 2018, Las Vegas, USA. It includes international faculty and medical staff as well as scientists and Pharma who will share cutting edge developments in the field, aiming at the development and implementation of strategies for the prevention, early detection and management of oncology issues.

ICECT USA 2018 is going with very exciting in the context of oncology and in particular in the field of Cancer therapeutics. A deeper understanding of the molecular mechanisms involved in the interaction between the tumour and the immune system is revealing an attractive set of novel therapeutic approaches to treat cancer. With some pronounced recent successes in this field, this is fuelling aggressive investigation, leading to new questions and challenges.

There have been several new developments in the field of oncology. There is a need for educational sessions for healthcare providers involved in the management of solid tumors.

Educational Objectives of ICECT USA 2018 conference

As a result of attending the Conference, At the conclusion of this conference, participants & learners will be able to:

• Patient Care : Formulate a diagnostic and management plan & Clearly document the plan in the medical record
• Medical Knowledge: Learn the appropriate diagnostic evaluation & the management of common cancers
• Practice-based Learning and Improvement: Use literature search to answer clinical questions, Be able to interpret laboratory tests and learn what additional tests to order to arrive at a diagnosis
• Identify and explain the latest trends in global research, methods, and technology in the treatment of cancers
• Interpret contemporary research findings on the prevention of and screening for cancers and be able to appropriately implement these findings into clinical practice;
• Examine the significance of novel approaches to the medical and surgical management of cancers within the context of the current standard of care and be able to integrate new therapies into clinical practice in an evidence-based manner;
• Assess the implications for future research and clinical practice of new developments in translational research on cancers; and demonstrate improvement in competence, performance and patient outcomes.

• State common treatment options available to patients with tumors.
• Identify indications, contra-indications, and side effects of available treatment options for cancer patients.
• Provide appropriate counseling and care to cancer patients receiving treatments, including immunotherapy, for their diseases.
• Provide appropriate care and counseling to patients receiving palliative care.
• Develop a multidisciplinary care plan of the patient undergoing cancer therapies for all types of cancers
• Select the best available care plan based on the individual and enhance communication throughout the decision-making process
• Address emerging evidence and improve personalized patient care
• Interview and examine a variety of patients representing the most common malignancies
• Research and discuss tumor biology and therapeutic options with the supervising medical oncologist
• Review current oncology treatment protocols available to each patient
• Decide on appropriate, cost-effective diagnostic tests and useful consultations
• Plan suitable palliative care for patients requiring pain control and other supportive measures
• Organize a follow-up plan including integration of social, nursing and nutritional support